• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T1 加权黑血磁共振上的血栓信号可预测急性下肢深静脉血栓导管溶栓的结局。

Thrombus Signal on T1-Weighted Black-Blood MR Predicts Outcomes of Catheter-Directed Thrombolysis in Acute Deep Vein Thrombosis.

机构信息

Department of Minimally Invasive Interventional Radiology, Guangzhou Panyu Central Hospital, Guangzhou, China.

Department of Radiology, Medical Imaging Institute of Panyu, Guangzhou Panyu Central Hospital, Guangzhou, China.

出版信息

Thromb Haemost. 2023 Apr;123(4):453-463. doi: 10.1055/s-0043-1760846. Epub 2023 Feb 8.

DOI:10.1055/s-0043-1760846
PMID:36754064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10060054/
Abstract

OBJECTIVES

Catheter-directed thrombolysis (CDT) is an effective therapy for acute deep vein thrombosis (DVT). However, predicting the CDT outcomes remains elusive. We hypothesized that the thrombus signal on T1-weighted black-blood magnetic resonance (MR) can provide insight into CDT outcomes in acute DVT patients.

METHODS

A total of 117 patients with acute iliofemoral DVT were enrolled for T1-weighted black-blood MR before CDT in this prospective study. Based on the signal contrast between thrombus and adjacent muscle, patients were categorized into the iso-intense thrombus (Iso-IT), hyper-intense thrombus (Hyper-IT), and mixed iso-/hyper-intense thrombi (Mixed-IT) groups. Immediate treatment outcome (i.e., vein patency) and long-term treatment outcome (i.e., the incidence rate of postthrombotic syndrome) were accessed by the same expert. Histological analysis and iron quantification were performed on thrombus samples to characterize the content of fibrin, collagen, and the ratio of Fe to total iron.

RESULTS

Compared to Mixed-IT and Hyper-IT groups, the Iso-IT group had the best lytic effect (90.5 ± 1.6% vs. 78.4 ± 2.6% vs. 46.5 ± 3.3%,  < 0.001), lowest bleeding ratio (0.0 vs. 11.8 vs. 13.3,  < 0.001), and the lowest incidence rate of postthrombotic syndrome on 24 months (3.6 vs. 18.4 vs. 63.4%,  < 0.001) following CDT. The Iso-IT group had a significantly lower ratio of Fe to total iron (93.1 ± 3.2% vs. 97.2 ± 2.1%,  = 0.034) and a higher content of fibrin (12.5 ± 5.3% vs. 4.76 ± 3.18%,  = 0.023) than Hyper-IT.

CONCLUSION

Thrombus signal characteristics on T1-weighted black-blood MR is associated with CDT outcomes and possesses potential to serve as a noninvasive approach to guide treatment decision making in acute DVT patients.

KEY POINTS

· Thrombus signal on T1-weighted black-blood MR is associated with lytic therapeutic outcome in acute DVT patients.. · Presence of iso-intense thrombus revealed by T1-weighted black-blood MRI is associated with successful thrombolysis, low bleeding ratio, and low incidence of the postthrombotic syndrome.. · T1-weighted thrombus signal characteristics may serve as a noninvasive imaging marker to predict CDT treatment outcomes and therefore guide treatment decision making in acute DVT patients..

摘要

目的

导管溶栓(CDT)是治疗急性深静脉血栓形成(DVT)的有效方法。然而,预测 CDT 结局仍然难以捉摸。我们假设 T1 加权黑血磁共振(MR)上的血栓信号可以深入了解急性 DVT 患者的 CDT 结局。

方法

在这项前瞻性研究中,共有 117 例急性髂股 DVT 患者在 CDT 前接受 T1 加权黑血 MR 检查。根据血栓与相邻肌肉之间的信号对比,患者分为等信号血栓(Iso-IT)、高信号血栓(Hyper-IT)和混合等/高信号血栓(Mixed-IT)组。由同一位专家评估即刻治疗结局(即静脉通畅)和长期治疗结局(即血栓后综合征发生率)。对血栓样本进行组织学分析和铁定量,以表征纤维蛋白、胶原和 Fe 与总铁的比值。

结果

与 Mixed-IT 和 Hyper-IT 组相比,Iso-IT 组的溶栓效果最好(90.5±1.6%比 78.4±2.6%比 46.5±3.3%,<0.001),出血比例最低(0.0 比 11.8 比 13.3,<0.001),CDT 后 24 个月血栓后综合征发生率最低(3.6 比 18.4 比 63.4%,<0.001)。Iso-IT 组的 Fe 与总铁的比值(93.1±3.2%比 97.2±2.1%,=0.034)显著较低,纤维蛋白含量(12.5±5.3%比 4.76±3.18%,=0.023)较高。

结论

T1 加权黑血 MR 上的血栓信号特征与 CDT 结局相关,有可能成为指导急性 DVT 患者治疗决策的一种非侵入性方法。

关键点

· T1 加权黑血 MR 上的血栓信号与急性 DVT 患者的溶栓治疗结局相关。

· T1 加权黑血 MRI 显示等信号血栓与溶栓成功、低出血比例和低血栓后综合征发生率相关。

· T1 加权血栓信号特征可作为一种无创性成像标志物,预测 CDT 治疗结局,从而指导急性 DVT 患者的治疗决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4fa/10060054/8cdcd948c52e/10-1055-s-0043-1760846-i22080410-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4fa/10060054/cfd37024db35/10-1055-s-0043-1760846-i22080410-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4fa/10060054/38984ea20e60/10-1055-s-0043-1760846-i22080410-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4fa/10060054/8f7f26cc06ab/10-1055-s-0043-1760846-i22080410-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4fa/10060054/792535c4a8a8/10-1055-s-0043-1760846-i22080410-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4fa/10060054/c6c876794cc5/10-1055-s-0043-1760846-i22080410-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4fa/10060054/8cdcd948c52e/10-1055-s-0043-1760846-i22080410-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4fa/10060054/cfd37024db35/10-1055-s-0043-1760846-i22080410-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4fa/10060054/38984ea20e60/10-1055-s-0043-1760846-i22080410-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4fa/10060054/8f7f26cc06ab/10-1055-s-0043-1760846-i22080410-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4fa/10060054/792535c4a8a8/10-1055-s-0043-1760846-i22080410-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4fa/10060054/c6c876794cc5/10-1055-s-0043-1760846-i22080410-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4fa/10060054/8cdcd948c52e/10-1055-s-0043-1760846-i22080410-6.jpg

相似文献

1
Thrombus Signal on T1-Weighted Black-Blood MR Predicts Outcomes of Catheter-Directed Thrombolysis in Acute Deep Vein Thrombosis.T1 加权黑血磁共振上的血栓信号可预测急性下肢深静脉血栓导管溶栓的结局。
Thromb Haemost. 2023 Apr;123(4):453-463. doi: 10.1055/s-0043-1760846. Epub 2023 Feb 8.
2
Comparative outcomes of catheter-directed thrombolysis versus AngioJet pharmacomechanical catheter-directed thrombolysis for treatment of acute iliofemoral deep vein thrombosis.导管溶栓与 AngioJet 机械溶栓导管治疗急性髂股深静脉血栓的疗效比较。
J Vasc Surg Venous Lymphat Disord. 2024 Jan;12(1):101669. doi: 10.1016/j.jvsv.2023.08.010. Epub 2023 Aug 23.
3
Coagulation-monitored, dose-adjusted catheter-directed thrombolysis or pharmaco-mechanical thrombus removal in deep vein thrombosis.在深静脉血栓形成中,进行监测凝血功能、剂量调整的导管直接溶栓或药物机械血栓清除。
Vasa. 2023 Nov;52(6):416-422. doi: 10.1024/0301-1526/a001097. Epub 2023 Oct 17.
4
Postthrombotic morbidity correlates with residual thrombus following catheter-directed thrombolysis for iliofemoral deep vein thrombosis.导管溶栓治疗髂股深静脉血栓后,血栓后发病率与残余血栓相关。
J Vasc Surg. 2012 Mar;55(3):768-73. doi: 10.1016/j.jvs.2011.10.032. Epub 2012 Jan 24.
5
Effectiveness and safety of catheter-directed thrombolysis in conjunction with percutaneous mechanical thrombectomy for acute iliofemoral deep vein thrombosis: A meta-analysis.经皮机械血栓切除术联合导管溶栓治疗急性髂股深静脉血栓形成的有效性和安全性:一项荟萃分析。
J Vasc Surg Venous Lymphat Disord. 2023 Jul;11(4):843-853.e2. doi: 10.1016/j.jvsv.2023.01.010. Epub 2023 Mar 7.
6
Meta-analysis of lytic catheter-based intervention for acute proximal deep vein thrombosis in the reduction of post-thrombotic syndrome.基于导管溶栓的急性近端深静脉血栓形成后血栓后综合征缓解的荟萃分析。
J Vasc Surg Venous Lymphat Disord. 2023 Jul;11(4):866-875.e1. doi: 10.1016/j.jvsv.2023.03.017. Epub 2023 Apr 7.
7
Catheter-directed thrombolysis through anterior tibial vein for treating acute extensive deep venous thrombosis.经胫骨前静脉置管溶栓治疗急性广泛型下肢深静脉血栓形成
J Vasc Surg Venous Lymphat Disord. 2018 Nov;6(6):681-688. doi: 10.1016/j.jvsv.2018.04.013. Epub 2018 Aug 17.
8
[Acute iliofemoral deep venous thrombosis should be treated with catheter-directed thrombolysis].急性髂股深静脉血栓形成应采用导管直接溶栓治疗。
Ugeskr Laeger. 2012 Apr 2;174(14):930-3.
9
Catheter-Directed Thrombolysis Protocols for Deep Venous Thrombosis of the Lower Extremities-A Systematic Review and Meta-analysis.下肢深静脉血栓形成的导管直接溶栓方案:系统评价和荟萃分析。
Thromb Haemost. 2024 Feb;124(2):89-104. doi: 10.1055/a-2106-3754. Epub 2023 Jun 6.
10
Comparison of Pharmacomechanical Catheter-Directed Thrombolysis versus Catheter-Directed Thrombolysis for the Treatment of Acute Iliofemoral Deep Vein Thrombosis: Measures of Long-Term Clinical Outcome and Quality of Life.比较药物机械性导管溶栓与导管溶栓治疗急性髂股静脉血栓形成:长期临床结局和生活质量的衡量标准。
Ann Vasc Surg. 2021 Oct;76:436-442. doi: 10.1016/j.avsg.2021.03.040. Epub 2021 Apr 25.

引用本文的文献

1
Exploring the efficacy of recombinant human pro-urokinase in catheter-directed thrombolysis for acute lower extremity deep venous thrombosis patients.探索重组人尿激酶原在急性下肢深静脉血栓形成患者导管直接溶栓中的疗效。
BMC Cardiovasc Disord. 2025 Apr 30;25(1):342. doi: 10.1186/s12872-025-04800-x.
2
Highlights of the society for magnetic resonance angiography 2024 conference.2024年磁共振血管造影学会会议亮点
J Cardiovasc Magn Reson. 2025 Mar 12;27(1):101878. doi: 10.1016/j.jocmr.2025.101878.

本文引用的文献

1
American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.美国血液学会2020年静脉血栓栓塞管理指南:深静脉血栓形成和肺栓塞的治疗
Blood Adv. 2020 Oct 13;4(19):4693-4738. doi: 10.1182/bloodadvances.2020001830.
2
Correlation between Post-Procedure Residual Thrombus and Clinical Outcome in Deep Vein Thrombosis Patients Receiving Pharmacomechanical Thrombolysis in a Multicenter Randomized Trial.多中心随机试验中接受药物机械溶栓治疗的深静脉血栓形成患者术后残余血栓与临床结局的相关性
J Vasc Interv Radiol. 2020 Oct;31(10):1517-1528.e2. doi: 10.1016/j.jvir.2020.07.010. Epub 2020 Sep 15.
3
Predictors of successful endovascular treatment in severe cerebral venous sinus thrombosis.
影响重症脑静脉窦血栓形成血管内治疗成功的因素。
Ann Clin Transl Neurol. 2019 Mar 7;6(4):755-761. doi: 10.1002/acn3.749. eCollection 2019 Apr.
4
How I treat the postthrombotic syndrome.如何治疗血栓后综合征。
Blood. 2018 May 17;131(20):2215-2222. doi: 10.1182/blood-2018-01-785956. Epub 2018 Mar 15.
5
Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis.药物机械性导管定向溶栓治疗深静脉血栓形成
N Engl J Med. 2017 Dec 7;377(23):2240-2252. doi: 10.1056/NEJMoa1615066.
6
Black-blood thrombus imaging (BTI): a contrast-free cardiovascular magnetic resonance approach for the diagnosis of non-acute deep vein thrombosis.黑血血栓成像(BTI):一种用于诊断非急性深静脉血栓形成的无对比剂心血管磁共振方法。
J Cardiovasc Magn Reson. 2017 Jan 18;19(1):4. doi: 10.1186/s12968-016-0320-8.
7
Thrombolysis for acute deep vein thrombosis.急性深静脉血栓形成的溶栓治疗
Cochrane Database Syst Rev. 2016 Nov 10;11(11):CD002783. doi: 10.1002/14651858.CD002783.pub4.
8
Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.抗栓治疗 VTE 疾病:CHEST 指南和专家小组报告。
Chest. 2016 Feb;149(2):315-352. doi: 10.1016/j.chest.2015.11.026. Epub 2016 Jan 7.
9
Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial.导管定向溶栓治疗深静脉血栓形成后血栓形成后综合征(CaVenT):一项开放标签随机对照试验的5年随访结果
Lancet Haematol. 2016 Feb;3(2):e64-71. doi: 10.1016/S2352-3026(15)00248-3. Epub 2016 Jan 6.
10
Interventional therapy for venous thromboembolism.介入治疗静脉血栓栓塞症。
J Thromb Haemost. 2015 Jun;13 Suppl 1:S245-51. doi: 10.1111/jth.12940.